AUSTIN, Texas, July 16, 2014 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. announced today that a new audio interview with VeriTeQ Corporation (“VeriTeQ” or the “Company”) (OTCQB:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, is now available. The interview with the Company’s Chairman and CEO Scott R. Silverman can be heard at http://smallcapvoice.com/blog/7-15-14-smallcapvoice-interview-with-veriteq-corp-vteq.

Mr. Silverman called in to SmallCapVoice.com to discuss the Company’s business and recent announcements, including the wide adoption throughout Europe of the Company’s Q Inside Safety Technology™, a micro-transponder used for medical device identification, as well as a recent order for more than 10,000 Q Inside Safety Technology micro-transponders from its customer Establishment Labs.

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

About VeriTeQ Corporation

VeriTeQ develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment. VeriTeQ offers the world’s first FDA cleared RFID microchip technology that can be used to identify implantable medical devices, in vivo, on demand, at the point of care. VeriTeQ’s dosimeters provide patient safety mechanisms while measuring and recording the dose of radiation delivered to a patient in real time. For more information on VeriTeQ, please visit www.veriteqcorp.com.

Statements in this press release and in the audio interview conducted by SmallCapVoice.com about VeriTeQ’s future expectations, constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and our actual results could differ materially from expected results. These risks and uncertainties include, without limitation, VeriTeQ’s ability to raise capital, as well as other risks. Additional information about these and other factors may be described in VeriTeQ’s Form 10-K, filed on April 15, 2014, and Forms 10-Q, filed on May 14, 2014, November 14, 2013, and August 9, 2013 and future filings with the Securities and Exchange Commission The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

PositiveID Corporation
Allison Tomek
561-805-8000

Contact for SmallCapVoice.com:

Stuart T. Smith
512-267-2430